TWD 85.1
(8.41%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 329 Thousand TWD | 34.87% |
2022 | 44.66 Million TWD | 57.53% |
2021 | 28.35 Million TWD | 56.86% |
2020 | 18.07 Million TWD | 275.35% |
2019 | -10.3 Million TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 27.05 Million TWD | -0.62% |
2023 FY | 60.23 Million TWD | 34.87% |
2023 Q4 | 27.22 Million TWD | 20.98% |
2023 Q2 | 22.5 Million TWD | 12.39% |
2022 Q4 | 20.02 Million TWD | 0.0% |
2022 FY | 44.66 Million TWD | 57.53% |
2021 FY | 28.35 Million TWD | 56.86% |
2020 FY | 18.07 Million TWD | 275.35% |
2019 FY | -10.3 Million TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 127.67 Million TWD | 99.742% |
Level Biotechnology Inc. | 151.99 Million TWD | 99.784% |
Sagittarius Life Science Corp | 135.85 Million TWD | 99.758% |
NeoCore Technology Co., Ltd. | 75.85 Million TWD | 99.566% |
TaiMed Biologics Inc. | 225.23 Million TWD | 99.854% |
GlycoNex Incorporation | 995 Thousand TWD | 66.935% |
VBI | 32.55 Million TWD | 98.989% |
GeneReach Biotechnology Corp. | 256.86 Million TWD | 99.872% |
Taiwan Advance Bio-Pharmaceutical Inc. | 194.18 Million TWD | 99.831% |
Visgeneer Inc. | 67.48 Million TWD | 99.512% |
Mycenax Biotech Inc. | -375.19 Million TWD | 100.088% |
Sunmax Biotechnology Co., Ltd. | 510.09 Million TWD | 99.936% |
G&E Herbal Biotechnology Co., Ltd. | 63.9 Million TWD | 99.485% |
Medigen Vaccine Biologics Corporation | 1.44 Billion TWD | 99.977% |
TaiwanJ Pharmaceuticals Co., Ltd. | 29.35 Million TWD | 98.879% |
Enimmune corporation | 220.1 Million TWD | 99.851% |
TaiRx, Inc. | 217.13 Million TWD | 99.848% |
CHO Pharma, Inc. | 268.99 Million TWD | 99.878% |
EirGenix Inc. | 236.74 Million TWD | 99.861% |
BioLASCO Taiwan Co., Ltd. | 104.35 Million TWD | 99.685% |
Sunny Pharmtech Inc. | 357.62 Million TWD | 99.908% |
Lin BioScience, Inc. | 1.09 Billion TWD | 99.97% |
BioGend Therapeutics Co., Ltd. | 266.15 Million TWD | 99.876% |
Feng Chi Biotech Corp. | 49.47 Million TWD | 99.335% |
Bio Preventive Medicine Corp. | 1.08 Million TWD | 69.621% |
Lukas Biomedical Inc. | 177.45 Million TWD | 99.815% |
RBC Bioscience Corporation | 58.35 Million TWD | 99.436% |
BiOptic Inc. | 108.69 Million TWD | 99.697% |
BRIM Biotechnology, Inc. | 90 Thousand TWD | -265.556% |
Shine-On BioMedical Co.,Ltd. | 69.35 Million TWD | 99.526% |
Great Novel Therapeutics Biotech & Medicals | 2.61 Million TWD | 87.419% |
Syngen Biotech Co.,Ltd. | 643.91 Million TWD | 99.949% |
SynCore Biotechnology Co.,Ltd | 46.02 Million TWD | 99.285% |
Genomics BioSci & Tech. Co.,Ltd. | 119.91 Million TWD | 99.726% |
Neith Corporation | 66.87 Million TWD | 99.508% |
Advagene Biopharma Co., Ltd. | 93.33 Million TWD | 99.648% |
NaviFUS Corp. | 11.82 Million TWD | 97.218% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 190.72 Million TWD | 99.828% |
Sinew Pharma Inc. | 186.25 Million TWD | 99.823% |
Andros Pharmaceuticals Co.,Ltd | 74.02 Million TWD | 99.556% |
Greenyn Biotechnology Co., Ltd | 220.39 Million TWD | 99.851% |
Lumosa Therapeutics Co., Ltd. | 41.48 Million TWD | 99.207% |
AP Biosciences Inc | 32.25 Million TWD | 98.98% |
Medigen Biotechnology Corp. | 1.85 Billion TWD | 99.982% |
3D Global Biotech Inc. | 5.27 Million TWD | 93.762% |
Pharmosa Biopharm Inc. | 317.32 Million TWD | 99.896% |
Intech Biopharm Corporation | -163.99 Million TWD | 100.201% |
Oneness Biotech Co., Ltd. | 1.12 Billion TWD | 99.971% |
Eusol Biotech Co.,Ltd. | 41.48 Million TWD | 99.207% |
TWi Biotechnology, Inc. | 169.55 Million TWD | 99.806% |
Ever Supreme Bio Technology Co., Ltd | 147.02 Million TWD | 99.776% |
TCI GENE Inc. | 174.61 Million TWD | 99.812% |
MegaPro Biomedical Co., Ltd | 18 Thousand TWD | -1727.778% |
Senhwa Biosciences, Inc. | 300.93 Million TWD | 99.891% |
Taiwan Bio Therapeutics Co., Ltd | 290.95 Million TWD | 99.887% |
NatureWise Biotech & Medicals Corporation | 83.94 Million TWD | 99.608% |
PharmaEngine, Inc. | 441.78 Million TWD | 99.926% |
Savior Lifetec Corporation | 223.36 Million TWD | 99.853% |
TaiGen Biopharmaceuticals Holdings Limited | 258.77 Million TWD | 99.873% |
OBI Pharma, Inc. | 2.01 Billion TWD | 99.984% |
Meribank Biotech Co., Ltd | 138.87 Million TWD | 99.763% |
Acepodia, Inc. | 452.56 Million TWD | 99.927% |
Caliway Biopharmaceuticals Co., Ltd. | 540.93 Million TWD | 99.939% |